To determine the extent to which PLK1 inhibition induces DNA damage in ER NSCLC cells, we incubated the cells with volasertib or erlotinib for 48 h and then subjected them to a comet assay which measures both single-strand and double-strand DNA breaks (Figure 5B). Here, PLK1 is linked to non-small cell lung carcinoma.